Market LIVE
Published markets; coverage varies by country
Product profile · United States

ABSORICA LD

 ·  Patent Litigation & Settlement History ↓

IngredientISOTRETINOIN
Application typeNDA
Application211913
Product003
Dosage formCAPSULE
RouteORAL
Strength20MG
Approval date2019-11-05
Marketing statusDiscontinued
Status event—
ApplicantSUN PHARM
Product source

Current GenericRadar decision

Year—
SelectionDISCONTINUED
ReviewFINAL
Anchor typeDISCONTINUATION
Anchor date—
Patent anchor—
Exclusivity anchor—
Protection date—
First Final ANDA—
Status event—

Discontinued in the original 2026-10-10 source. Actual marketing-discontinuation date is unverified. Evidence limits: actual discontinuation date unavailable; do not substitute the observation date or approval year.

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
97507112035-05-29DP ————
[GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.
———
97507112035-05-29DP ————
Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.
———
97005352035-08-04DP ————
[GNR_US204_50] Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.
———
97005352035-08-04DP ————
Not used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
No exclusivity facts are recorded in this product snapshot.

2026-10-10 · CURRENT_SNAPSHOT_NO_RECORD · Historical coverage: NOT_COMPLETE

2026-10-10 · NO_RECORD_IN_CURRENT_SNAPSHOT · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
075945 / 002FINAL_APPROVAL · FINAL_APPROVED2002-11-08—MYLAN PHARMACEUTICALS INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076041 / 002FINAL_APPROVAL · FINAL_APPROVED2002-12-24—SUN PHARMACEUTICAL INDUSTRIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076135 / 002FINAL_APPROVAL · FINAL_APPROVED2003-04-11—TEVA PHARMACEUTICALS USANEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
076485 / 002FINAL_APPROVAL · FINAL_APPROVED2012-01-19—UPSHER SMITH LABORATORIES LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
202099 / 002FINAL_APPROVAL · FINAL_APPROVED2013-03-25—DR REDDYS LABORATORIES LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
207792 / 002FINAL_APPROVAL · FINAL_APPROVED2017-09-29—AMNEAL PHARMACEUTICALS OF NY LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
205063 / 002FINAL_APPROVAL · FINAL_APPROVED2021-03-31—ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
212333 / 002FINAL_APPROVAL · FINAL_APPROVED2021-09-21—UPSHER SMITH LABORATORIES LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
211568 / 002FINAL_APPROVAL · FINAL_APPROVED2023-08-29—ZYDUS PHARMACEUTICALS USA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
218194 / 002FINAL_APPROVAL · FINAL_APPROVED2024-01-29—AUROBINDO PHARMA LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
216633 / 002FINAL_APPROVAL · FINAL_APPROVED2025-05-22—ZYDUS PHARMACEUTICALS USA INCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
216097 / 002FINAL_APPROVAL · FINAL_APPROVED2025-10-07—AMNEAL PHARMACEUTICALS OF NY LLCNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource
220336 / 001FINAL_APPROVAL · FINAL_APPROVED2026-09-10—AUROBINDO PHARMA LTDNEXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 13 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
075945 / 002MYLAN PHARMACEUTICALS INCFINAL_APPROVAL · FINAL_APPROVED2002-11-08 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
076041 / 002SUN PHARMACEUTICAL INDUSTRIES LTDFINAL_APPROVAL · FINAL_APPROVED2002-12-24 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
076135 / 002TEVA PHARMACEUTICALS USAFINAL_APPROVAL · FINAL_APPROVED2003-04-11 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
076485 / 002UPSHER SMITH LABORATORIES LLCFINAL_APPROVAL · FINAL_APPROVED2012-01-19 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
202099 / 002DR REDDYS LABORATORIES LTDFINAL_APPROVAL · FINAL_APPROVED2013-03-25 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
207792 / 002AMNEAL PHARMACEUTICALS OF NY LLCFINAL_APPROVAL · FINAL_APPROVED2017-09-29 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
205063 / 002ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INCFINAL_APPROVAL · FINAL_APPROVED2021-03-31 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
212333 / 002UPSHER SMITH LABORATORIES LLCFINAL_APPROVAL · FINAL_APPROVED2021-09-21 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
211568 / 002ZYDUS PHARMACEUTICALS USA INCFINAL_APPROVAL · FINAL_APPROVED2023-08-29 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
218194 / 002AUROBINDO PHARMA LTDFINAL_APPROVAL · FINAL_APPROVED2024-01-29 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
216633 / 002ZYDUS PHARMACEUTICALS USA INCFINAL_APPROVAL · FINAL_APPROVED2025-05-22 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
216097 / 002AMNEAL PHARMACEUTICALS OF NY LLCFINAL_APPROVAL · FINAL_APPROVED2025-10-07 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
220336 / 001AUROBINDO PHARMA LTDFINAL_APPROVAL · FINAL_APPROVED2026-09-10 EXACT_PRODUCT · PENDING_PRODUCT_MAPPINGSource—
Decision evidence (2)
TypeDateRoleBasisSource
PATENT2035-05-29LISTING_CONTEXTNot used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.Source
PATENT2035-08-04LISTING_CONTEXTNot used as a canonical patent anchor for the DISCONTINUED decision; does not establish complete claim verification.Source
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.